Title of article :
Depakine Induced Pseudo-Pelger-Huet Anomaly
Author/Authors :
Valizadeh, Nasim Assistant Professor of Hematology and Medical Oncology - Tehran University of Medical Sciences - Iran University of Medical Sciences, Tehran , Hoshangian Tehrani, Nasim Assistant professor of Internal medicine - Iran University of Medical sciences, Tehran
Abstract :
Pelger-Huët anomaly is a rare benign autosomaldominant anomaly with incidence of about 1 in 6000 persons. Pelger-Huët cells are morphologically abnormal
neutrophils that are either bilobed or completely unsegmented.1,2 It should be differentiated from acquired or pseudo-Pelger-Huët anomaly (PPHA), which has
similar morphology and association with different
pathological states like myelodysplasia, Acute myeloid
leukemia (AML), chronic myelogenous leukemia (CML)
as well as with certain infections and drugs (Valproate
and Ibuprofen). An 18-year-old woman who was a case of mental
retardation since early childhood was admitted with
episodes of epistaxis and pancytopenia. She had a
history of end stage renal disease on chronic intermittent
dialysis and history of seizure on sodium valproate and
nitrazepam. Since 1 month ago valproate dosage was
increased from 200 mg twice a day to 500 mg twice a
day. Physical examination showed pallor, and inability to
speak and follow orders. There was no lymphadenopathy
and organomegaly. Laboratory findings showed WBC:
3300/µL, Hb: 6 gr/dl, Platelet: 45000/µL, Creatinine: 7
mg/dL. Peripheral blood smear showed many bi-lobed neutrophils (pseudo pelger huet cells)...
Keywords :
Depakine Induced , Pseudo-Pelger-Huet Anomaly , AML , Peripheral blood
Journal title :
Iranian Journal of Blood and Cancer (IJBC)